To investigate whether IFN-γ and TNF treatment can also activate the PD-L1CON gene expression signature in cell lines, we analysed an independent RNA-seq dataset (GSE152755) [20] where eight melanoma cell lines were treated with either IFN-γ for 2 to 5 weeks, or TNF for 3 days. This evidence concerns the gene IFNG and melanoma.